BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...
The FDA approves Teligent's (TLGT +13.7%) Gentamicin Sulfate Cream USP, 0.1%. Per IQVIA, the U.S. market is ~$15.6M. To ensure this doesn’t happen in the future ...
Teligent has received the Food and Drug Administration’s clearance for gentamicin sulfate cream, 0.1% (gentamicin base). The product has a market value of roughly $15.6 million, according to IQVIA ...
Credit: Shutterstock. Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler. The Food and Drug Administration (FDA) has cleared Cerament G for use as a bone void filler in skeletally ...
This leaflet answers some common questions about DBL Gentamicin Injection BP. It does not contain all the available information. It does not take the place of talking to your healthcare professional.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback